Clinical Trial Update: PSMA-PET for Biopsy and Treatment Guidance in Primary Prostate Cancer [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating PSMA-PET to guide biopsy and treatment decisions in primary prostate cancer has completed with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Prostate Cancer

Snippet

Sponsor: Indiana University | Conditions: Prostate Cancer | Phase 2 | Status: COMPLETED | Results posted: 2023-05-08